Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study.
Front Oncol
; 12: 900010, 2022.
Article
en En
| MEDLINE
| ID: mdl-36212437
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Idioma:
En
Año:
2022
Tipo del documento:
Article